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The requirement of membrane cholesterol in maintaining ligand binding activity of the hippocampal serotonin1A receptor has previ-
ously been demonstrated. In order to test the stringency of the requirement of cholesterol, we depleted cholesterol from native hippo-
campal membranes followed by replenishment with 7-dehydrocholesterol. The latter sterol is an immediate biosynthetic precursor of
cholesterol differing only in a double bond at the 7th position in the sterol ring. Our results show, for the first time, that replenishment
with 7-dehydrocholesterol does not restore ligand binding activity of the serotonin1A receptor, in spite of recovery of the overall mem-
brane order. The requirement for restoration of ligand binding activity therefore is more stringent than the requirement for the recovery
of overall membrane order. These novel results have potential implications in understanding the interaction of membrane lipids with this
important neuronal receptor under pathogenic conditions such as the Smith-Lemli-Opitz syndrome.
 2007 Elsevier Inc. All rights reserved.
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tors (GPCRs) constitute one of the largest family of pro-
teins in mammals and account for 2% of the total
proteins coded by the human genome [1]. GPCRs represent
major targets for the development of novel drug candidates
in all clinical areas [2]. The serotonin1A (5-HT1A) receptor
is an important GPCR and is the most extensively studied
among the serotonin receptors. The serotonin1A receptor is
involved in a variety of cognitive, behavioral, and develop-
mental functions (for a recent review, see [3]). The seroto-0006-291X/$ - see front matter  2007 Elsevier Inc. All rights reserved.
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mino)tetralin; 7-DHCR, 3b-hydroxy-steroid-D7-reductase; DMPC, dimyr-
istoyl-sn-glycero-3-phosphocholine; DPH, 1,6-diphenyl-1,3,5-hexatriene;
GPCR, G-protein coupled receptor; MbCD, methyl-b-cyclodextrin;
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syndrome.
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E-mail address: amit@ccmb.res.in (A. Chattopadhyay).nin1A receptor agonists and antagonists represent major
classes of molecules with potential therapeutic effects in
anxiety- or stress-related disorders. Interestingly, mice
lacking the serotonin1A receptor exhibit enhanced anxi-
ety-related behavior [4] and represent an important animal
model for genetic vulnerability to conditions such as anxi-
ety disorders and aggression [5].
Cholesterol is an abundant and essential component of
eukaryotic membranes and plays a crucial role in mem-
brane organization, dynamics, function, and sorting [6].
Interestingly, the central nervous system which accounts
for only 2% of the body mass contains 25% of free cho-
lesterol present in the whole body [7]. Brain cholesterol is
synthesized in situ and is developmentally regulated. As a
result, a number of neurological diseases share a common
etiology of defective cholesterol metabolism in the brain
[8]. In the Smith-Lemli-Opitz syndrome (SLOS), for exam-
ple, the marked abnormalities in brain development and
function leading to serious neurological and mental dys-
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of brain cholesterol comes from the in situ synthesis and
such synthesis is defective in this syndrome [9]. SLOS is
caused by mutations in 3b-hydroxy-steroid-D7-reductase
(7-DHCR), an enzyme required in the final step of choles-
terol biosynthesis. Elevated plasma levels of 7- and 8-dehy-
drocholesterol and the ratio of their contents to that of
cholesterol are representative parameters for diagnosis of
SLOS. The effect of alteration in the cholesterol content
of neuronal membranes on membrane dynamics and pro-
tein/receptor function therefore represents an important
determinant in the analysis of neurogenesis and several
neuropathologies.
We have previously shown the requirement of mem-
brane cholesterol in maintaining ligand binding activity
of the hippocampal serotonin1A receptor [10,11]. In order
to further examine the stringency of cholesterol require-
ment, we have tested whether 7-DHC, an immediate bio-
synthetic precursor of cholesterol differing only in its
unsaturation at 7th position in the sterol ring (see Fig. 1),
can support the ligand binding activity of the hippocampal
serotonin1A receptor.
Materials and methods
Materials. Cholesterol, 7-DHC, MbCD, DMPC, DPH, EDTA,
EGTA, MgCl2, MnCl2, iodoacetamide, PMSF, serotonin, sucrose, poly-
ethylenimine, sodium azide, and Tris were obtained from Sigma Chemical
Co. (St. Louis, MO, USA). BCA reagent for protein estimation was from
Pierce (Rockford, IL, USA). [3H]8-OH-DPAT (sp. activity 135 Ci/mmol)
was purchased from DuPont New England Nuclear (Boston, MA, USA).
GF/B glass microfiber filters were from Whatman International (Kent,
UK). All solvents used were of analytical grade. Pre-coated silica gel 60
thin-layer chromatography plates were from Merck (Darmstadt, Ger-
many). All other chemicals used were of the highest purity available.
Water was purified through a Millipore (Bedford, MA, USA) Milli-Q
system and used throughout. Fresh bovine brains were obtained from a
local slaughterhouse within 10 min of death and the hippocampal region
was carefully dissected out. The hippocampi were immediately flash frozen
in liquid nitrogen and stored at 70 C till further use.
Preparation of native hippocampal membranes. Native hippocampal
membranes were prepared as described earlier [10]. Protein concentration
was determined using the BCA reagent with bovine serum albumin as a
standard [12].Fig. 1. Chemical structures of cholesterol and 7-dehydrocholesterol. The
principal route of cholesterol synthesis in humans is the Kandutsch-
Russell pathway [20]. In this pathway, the immediate precursor of
cholesterol is 7-dehydrocholesterol which differs only in its unsaturation at
7th position in the sterol ring (highlighted in its chemical structure).
Elevated levels of 7-dehydrocholesterol have been characterized as a
diagnostic parameter of the Smith-Lemli-Opitz syndrome. See text for
more details.Radioligand binding assays. Receptor binding assays were carried out
as described earlier [10] using 0.5 mg total protein. Briefly, tubes in
duplicate with 0.5 mg protein in a total volume of 1 ml of buffer (50 mM
Tris, 1 mM EDTA, 10 mM MgCl2, 5 mM MnCl2, pH 7.4) were incubated
with the radiolabeled agonist [3H]8-OH-DPAT (final concentration in
assay tube being 0.29 nM) for 1 h at 25 C. Nonspecific binding was
determined by performing the assay in the presence of 10 lM serotonin.
The binding reaction was terminated by rapid filtration under vacuum in a
Millipore multiport filtration apparatus through Whatman GF/B 2.5 cm
diameter glass microfiber filters (1.0 lm pore size), which were presoaked
in 0.15% polyethylenimine for 1 h. Filters were then washed three times
with 3 ml of cold water (4 C), dried and the retained radioactivity was
measured in a Packard Tri-Carb 1500 liquid scintillation counter using
5 ml of scintillation fluid.
Cholesterol depletion of native membranes. Native hippocampal mem-
branes were depleted of cholesterol using MbCD as described previously
[10]. Briefly, membranes resuspended at a protein concentration of 2 mg/
ml were treated with 40 mMMbCD in 50 mM Tris, pH 7.4, buffer at 25 C
with constant shaking for 1 h. Membranes were then spun down at
50,000g for 5 min at 4 C, washed with 50 mM Tris, pH 7.4, buffer and
resuspended in the same buffer.
7-Dehydrocholesterol and cholesterol replenishment of cholesterol-
depleted membranes. Cholesterol-depleted hippocampal membranes were
replenished with 7-dehydrocholesterol (7-DHC) or cholesterol using either
7-DHC-MbCD or cholesterol-MbCD complex which are soluble in water.
The complex was prepared by dissolving the required amounts of 7-DHC
or cholesterol and MbCD in a ratio of 1:10 (mol/mol) in 50 mM Tris, pH
7.4, buffer by constant shaking at 25 C. Stock solutions (typically 2 mM
7-DHC (or cholesterol):20 mM MbCD) of this complex were freshly
prepared before each experiment. 7-DHC and cholesterol replenishment
were carried out at a protein concentration of 2 mg/ml by incubating the
cholesterol-depleted membranes with 1 mM 7-DHC (or cholesterol):
10 mM MbCD complex for 1 h in 50 mM Tris, pH 7.4, buffer at 25 C
under constant shaking. Membranes were then spun down at 50,000g for
5 min at 4 C, washed with 50 mM Tris, pH 7.4, buffer and resuspended in
the same buffer.
Estimation of 7-DHC and cholesterol by thin-layer chromatography.
Lipid extraction from native, cholesterol-depleted, and membranes
replenished with 7-DHC or cholesterol after cholesterol depletion using
40 mMMbCD was carried out according to Bligh and Dyer [13]. The lipid
extracts were dried under a stream of nitrogen at 45 C. The dried extracts
were resuspended in a mixture of chloroform/methanol (1:1, v/v). 7-DHC
and cholesterol were resolved by thin-layer chromatography (TLC). TLC
plates were impregnated with a 3% (w/v) silver nitrate solution in 97%
methanol, allowed to dry briefly and activated at 120 C for 15 min. Total
lipid extracts were separated using n-heptane/ethylacetate (2:1, v/v) as the
solvent system [14]. The separated lipids were visualized by charring with a
solution containing cupric sulfate (10%, w/v) and phosphoric acid (8%, v/
v) at 150 C. 7-DHC and cholesterol were used as standards to identify 7-
DHC and cholesterol bands on the thin-layer chromatogram run with
lipid extracts from native, cholesterol-depleted, and 7-DHC or cholesterol
replenished hippocampal membranes. The TLC plates were scanned and
lipid band intensities were analyzed using the Adobe Photoshop software
version 5.0 (Adobe Systems, San Jose, CA, USA). Intensities of the sterols
(7-DHC and cholesterol) from all samples on the TLC plate were nor-
malized to the intensity of the cholesterol band obtained from the native
membrane.
Estimation of inorganic phosphate. Concentration of lipid phosphate
was determined subsequent to total digestion by perchloric acid [15] using
Na2HPO4 as standard. DMPC was used as an internal standard to assess
lipid digestion. Samples without perchloric acid digestion produced neg-
ligible readings.
Fluorescence anisotropy measurements. Fluorescence anisotropy mea-
surements were carried out with fluorescent membrane probe DPH with a
Hitachi F-4010 spectrofluorometer using 1 cm path length quartz cuvettes
at room temperature (23 C) as described earlier [16]. Excitation and
emission wavelengths were set at 358 and 430 nm. Excitation and emission
slits with nominal bandpasses of 1.5 and 20 nm were used. The optical
Fig. 2. Estimation of sterol content of native and cholesterol-depleted
hippocampal membranes, and cholesterol-depleted membranes replen-
ished with varying concentrations of sterols (7-DHC and cholesterol).
Total lipids extracted from native membranes, membranes treated with
40 mM MbCD, and cholesterol-depleted membranes replenished with
varying concentrations of MbCD and sterols were separated by thin layer
chromatography as shown in (A). The lanes represent lipids extracted
from native membranes (lane 2), membranes treated with 40 mM MbCD
(lane 3), and membranes treated with 40 mM MbCD followed by
replenishment with 1 mM cholesterol (lane 4), 0.5 mM of 7-DHC (lane
5) and 1 mM 7-DHC (lane 6). The arrows represent positions of
cholesterol and 7-DHC on the thin layer chromatogram identified using
standards in lane 1. Cholesterol (open bars), 7-DHC (gray bars) and total
sterol (black bars) were quantified by densiometric analysis of the thin
layer chromatogram and are shown in (B). Values are expressed as
percentages of the cholesterol content of native membranes without any
treatment and total sterol content of membranes were obtained by the
addition of 7-DHC and cholesterol contents. Data represent means ± SE
of at least three independent experiments. See Materials and methods for
other details.
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ropy values remained identical even after dilution of membrane samples,
indicating the absence of any scattering artifact [17]. Fluorescence
anisotropy measurements were performed using a Hitachi polarization
accessory. Anisotropy values were calculated from the equation [18]:
r ¼ IVV  GIVH
IVV þ 2GIVH ð1Þ
where IVV and IVH are the measured fluorescence intensities (after appro-
priate background subtraction) with the excitation polarizer vertically ori-
ented and the emission polarizer vertically and horizontally oriented,
respectively. G is the grating correction factor and is equal to IHV/IHH.
All experiments were done with multiple sets of samples and average val-
ues of fluorescence anisotropy are shown in Fig. 4.
Results and discussion
Cholesterol depletion of native hippocampal mem-
branes was carried out using the water-soluble compound
MbCD which has previously been shown to selectively
and efficiently extract cholesterol from membranes [10].
Fig. 2 shows the extents of replenishment of 7-DHC and
cholesterol into hippocampal membranes treated with
40 mM MbCD. Treatment of membranes with 40 mM
MbCD results in 61% reduction in the cholesterol content
(Fig. 2B). This is accompanied by a corresponding reduc-
tion (56%) in the specific [3H]8-OH-DPAT binding (see
Fig. 3). Replenishment with 1 mM cholesterol resulted in
recovery of specific agonist binding to 65% of native
membranes (Fig. 3) even when 87% of the cholesterol
could be replenished (Fig. 2B). In order to monitor whether
replenishment with 7-DHC could restore the specific [3H]8-
OH-DPAT binding, cholesterol-depleted membranes were
replenished with 0.5 and 1 mM 7-DHC. Importantly, the
total sterol content (7-DHC + cholesterol) appears to be
comparable to native membranes, especially when loading
was carried out with 1 mM 7-DHC (Fig. 2B). Interestingly,
even when loading was carried out with 1 mM 7-DHC, the
specific agonist binding could not be restored (Fig. 3) in
spite of the fact that the extent of loading of 7-DHC was
similar to what was obtained with 1 mM cholesterol
(Fig. 2B). We interpret this to be due to the inability of
7-DHC in restoring the specific agonist binding activity
of the hippocampal serotonin1A receptor.
The observed difference between cholesterol and 7-
DHC, in terms of being able to restore the ligand binding
activity (Fig. 3), could be due to an alteration in overall
membrane organization (order). In order to monitor
whether there is a change in overall membrane order when
cholesterol-depleted membranes were replenished with cho-
lesterol or 7-DHC, fluorescence anisotropy measurements
were carried out with the membrane probe, DPH. Fluores-
cence anisotropy measured using probes such as DPH is
correlated to the rotational diffusion of membrane embed-
ded probes [18], which is sensitive to the packing of lipid
chains. Fig. 4 shows that the fluorescence anisotropy of
DPH exhibits a significant reduction upon cholesterol
depletion from native membranes. Interestingly, when cho-
lesterol-depleted membranes were replenished with eithercholesterol or 7-DHC, the fluorescence anisotropy was
found to be similar to that of native (control) membranes.
This indicates that the overall membrane order is unaltered
upon replenishment. The requirement for restoration of
ligand binding activity is therefore more stringent than
the requirement for the recovery of overall membrane
order.
We have earlier reported that membrane cholesterol is
required in maintaining ligand binding activity of the hip-
pocampal serotonin1A receptor [11]. In order to test the
stringency of the requirement of cholesterol in maintaining
the function of the hippocampal serotonin1A receptor, in
this paper we have replaced cholesterol with 7-DHC, the
Fig. 3. Effect of replenishment of 7-DHC and cholesterol into cholesterol-
depleted membranes on the specific binding of the [3H]8-OH-DPAT to the
hippocampal serotonin1A receptor. Native membranes were treated with
40 mM MbCD and were replenished with varying concentrations of 7-
DHC and cholesterol. Values are expressed as percentages of the specific
binding obtained in native membranes. The data shown are means ± SE
from at least five independent experiments. See Materials and methods for
other details.
Fig. 4. Effect of replenishment of 7-DHC and cholesterol into cholesterol-
depleted membranes on fluorescence anisotropy of the membrane probe
DPH. Cholesterol depletion was carried out using 40 mM MbCD.
Fluorescence anisotropy experiments were performed with membranes
containing 50 nmol phospholipid at a probe to phospholipid ratio of 1:100
(mol/mol) at room temperature (23 C). The values represent the
means ± SE of duplicate points from at least three independent experi-
ments. See Materials and methods for other details.
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bond in 7-DHC at the 7th position. Our results show that
7-DHC does not support the ligand binding activity of the
hippocampal serotonin1A receptor. This is in spite of thefact that replenishment with 7-DHC restores overall mem-
brane order to that of native membranes. We have previ-
ously shown that membrane cholesterol oxidation leads
to inhibition of the ligand binding activity of the hippo-
campal serotonin1A receptor without changing membrane
order [19]. Taken together, our results indicate that the
molecular basis for the requirement of membrane choles-
terol in maintaining the ligand binding activity of seroto-
nin1A receptors could be specific interaction, although
global bilayer effects may not be ruled out. These results
have potential implications in understanding the interac-
tion of membrane lipids with this important neuronal
receptor under SLOS-like condition in which 7-DHC accu-
mulates due to mutations in the DHCR7 gene.Acknowledgments
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